These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28750581)

  • 21. Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia.
    Rees E; Kendall K; Pardiñas AF; Legge SE; Pocklington A; Escott-Price V; MacCabe JH; Collier DA; Holmans P; O'Donovan MC; Owen MJ; Walters JTR; Kirov G
    JAMA Psychiatry; 2016 Sep; 73(9):963-969. PubMed ID: 27602560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH.
    Bittel DC; Yu S; Newkirk H; Kibiryeva N; Holt A; Butler MG; Cooley LD
    Cytogenet Genome Res; 2009; 124(2):113-20. PubMed ID: 19420922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An attempt to identify 22q11.2 microdeletions in samples of the Hungarian schizophrenia DNA bank by multiplex ligation-based probe amplification (MLPA): literature review, methodology and results].
    Klein I; Szocs K; Vincze K; Benkovits J; Somogyi S; Herman L; Rethelyi JM
    Neuropsychopharmacol Hung; 2016 Dec; 18(4):209-218. PubMed ID: 28259864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome.
    Mlynarski EE; Xie M; Taylor D; Sheridan MB; Guo T; Racedo SE; McDonald-McGinn DM; Chow EW; Vorstman J; Swillen A; Devriendt K; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Philip N; Simon TJ; Roberts AE; Piotrowicz M; Bearden CE; Eliez S; Gothelf D; Coleman K; Kates WR; Devoto M; Zackai E; Heine-Suñer D; Goldmuntz E; Bassett AS; Morrow BE; Emanuel BS;
    Hum Genet; 2016 Mar; 135(3):273-85. PubMed ID: 26742502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.
    Sønderby IE; Gústafsson Ó; Doan NT; Hibar DP; Martin-Brevet S; Abdellaoui A; Ames D; Amunts K; Andersson M; Armstrong NJ; Bernard M; Blackburn N; Blangero J; Boomsma DI; Bralten J; Brattbak HR; Brodaty H; Brouwer RM; Bülow R; Calhoun V; Caspers S; Cavalleri G; Chen CH; Cichon S; Ciufolini S; Corvin A; Crespo-Facorro B; Curran JE; Dale AM; Dalvie S; Dazzan P; de Geus EJC; de Zubicaray GI; de Zwarte SMC; Delanty N; den Braber A; Desrivières S; Donohoe G; Draganski B; Ehrlich S; Espeseth T; Fisher SE; Franke B; Frouin V; Fukunaga M; Gareau T; Glahn DC; Grabe H; Groenewold NA; Haavik J; Håberg A; Hashimoto R; Hehir-Kwa JY; Heinz A; Hillegers MHJ; Hoffmann P; Holleran L; Hottenga JJ; Hulshoff HE; Ikeda M; Jahanshad N; Jernigan T; Jockwitz C; Johansson S; Jonsdottir GA; Jönsson EG; Kahn R; Kaufmann T; Kelly S; Kikuchi M; Knowles EEM; Kolskår KK; Kwok JB; Hellard SL; Leu C; Liu J; Lundervold AJ; Lundervold A; Martin NG; Mather K; Mathias SR; McCormack M; McMahon KL; McRae A; Milaneschi Y; Moreau C; Morris D; Mothersill D; Mühleisen TW; Murray R; Nordvik JE; Nyberg L; Olde Loohuis LM; Ophoff R; Paus T; Pausova Z; Penninx B; Peralta JM; Pike B; Prieto C; Pudas S; Quinlan E; Quintana DS; Reinbold CS; Marques TR; Reymond A; Richard G; Rodriguez-Herreros B; Roiz-Santiañez R; Rokicki J; Rucker J; Sachdev P; Sanders AM; Sando SB; Schmaal L; Schofield PR; Schork AJ; Schumann G; Shin J; Shumskaya E; Sisodiya S; Steen VM; Stein DJ; Steinberg S; Strike L; Teumer A; Thalamuthu A; Tordesillas-Gutierrez D; Turner J; Ueland T; Uhlmann A; Ulfarsson MO; van 't Ent D; van der Meer D; van Haren NEM; Vaskinn A; Vassos E; Walters GB; Wang Y; Wen W; Whelan CD; Wittfeld K; Wright M; Yamamori H; Zayats T; Agartz I; Westlye LT; Jacquemont S; Djurovic S; Stefánsson H; Stefánsson K; Thompson P; Andreassen OA;
    Mol Psychiatry; 2020 Mar; 25(3):584-602. PubMed ID: 30283035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that duplications of 22q11.2 protect against schizophrenia.
    Rees E; Kirov G; Sanders A; Walters JT; Chambert KD; Shi J; Szatkiewicz J; O'Dushlaine C; Richards AL; Green EK; Jones I; Davies G; Legge SE; Moran JL; Pato C; Pato M; Genovese G; Levinson D; Duan J; Moy W; Göring HH; Morris D; Cormican P; Kendler KS; O'Neill FA; Riley B; Gill M; Corvin A; ; Craddock N; Sklar P; Hultman C; Sullivan PF; Gejman PV; McCarroll SA; O'Donovan MC; Owen MJ
    Mol Psychiatry; 2014 Jan; 19(1):37-40. PubMed ID: 24217254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis.
    Williams NM; Zaharieva I; Martin A; Langley K; Mantripragada K; Fossdal R; Stefansson H; Stefansson K; Magnusson P; Gudmundsson OO; Gustafsson O; Holmans P; Owen MJ; O'Donovan M; Thapar A
    Lancet; 2010 Oct; 376(9750):1401-8. PubMed ID: 20888040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the clinical manifestations of 16p11.2 deletion syndrome: a series of developmental case reports in children.
    Fetit R; Price DJ; Lawrie SM; Johnstone M
    Psychiatr Genet; 2020 Oct; 30(5):136-140. PubMed ID: 32732550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-cause mortality and survival in adults with 22q11.2 deletion syndrome.
    Van L; Heung T; Graffi J; Ng E; Malecki S; Van Mil S; Boot E; Corral M; Chow EWC; Hodgkinson KA; Silversides C; Bassett AS
    Genet Med; 2019 Oct; 21(10):2328-2335. PubMed ID: 30948858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome.
    Smyk M; Geremek M; Ziemkiewicz K; Gambin T; Kutkowska-Kaźmierczak A; Kowalczyk K; Plaskota I; Wiśniowiecka-Kowalnik B; Bartnik-Głaska M; Niemiec M; Grad D; Piotrowicz M; Gieruszczak-Białek D; Pietrzyk A; Crowley TB; Giunta V; McGinn DE; Zackai EH; Tran O; Emanuel BS; McDonald-McGinn DM; Nowakowska BA
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
    Gur RE; Bassett AS; McDonald-McGinn DM; Bearden CE; Chow E; Emanuel BS; Owen M; Swillen A; Van den Bree M; Vermeesch J; Vorstman JAS; Warren S; Lehner T; Morrow B
    Mol Psychiatry; 2017 Dec; 22(12):1664-1672. PubMed ID: 28761081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation.
    Guilmatre A; Dubourg C; Mosca AL; Legallic S; Goldenberg A; Drouin-Garraud V; Layet V; Rosier A; Briault S; Bonnet-Brilhault F; Laumonnier F; Odent S; Le Vacon G; Joly-Helas G; David V; Bendavid C; Pinoit JM; Henry C; Impallomeni C; Germano E; Tortorella G; Di Rosa G; Barthelemy C; Andres C; Faivre L; Frébourg T; Saugier Veber P; Campion D
    Arch Gen Psychiatry; 2009 Sep; 66(9):947-56. PubMed ID: 19736351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
    Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
    Elife; 2022 Aug; 11():. PubMed ID: 36039635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case history and genome-wide scans for copy number variants in a family with patient having 15q11.1-q11.2 duplication and 22q11.2 deletion, and schizophrenia.
    Takahashi S; Suzuki T; Nakamura-Tomizuka S; Osaki K; Sotome Y; Sagawa T; Uchiyama M
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):229-35. PubMed ID: 25776014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic components of microdeletion syndromes and their role in determining schizophrenia traits.
    Biswal SR; Kumar A; Muthuswamy S; Kumar S
    Mol Biol Rep; 2024 Jul; 51(1):804. PubMed ID: 39001960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach.
    Michaelovsky E; Carmel M; Frisch A; Salmon-Divon M; Pasmanik-Chor M; Weizman A; Gothelf D
    Transl Psychiatry; 2019 Jan; 9(1):15. PubMed ID: 30710087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.